Canadian society of nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management

American Journal of Kidney Diseases

Volumn 65, Issue 2, 2015, Pages 177-205

  Akbari, Ayub ^a   Clase, Catherine M ^b,c   Acott, Phil ^d,e   Battistella, Marisa ^f   Bello, Aminu ^g   Feltmate, Patrick ^d   Grill, Allan ^h,i,j   Karsanji, Meena ^k   Komenda, Paul ^l   Madore, Francois ^m   Manns, Braden J ⁿ   Mahdavi, Sara ^o   Mustafa, Reem A ^c,p   Smyth, Andrew ^q   Welcher, E Sohani ^r  

^a UNIVERSITY OF OTTAWA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e IWK HEALTH CENTRE   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h SUNNYBROOK RESEARCH INSTITUTE   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j CANCER CARE ONTARIO   (Canada)

^k VANCOUVER COASTAL HEALTH   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

^m UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁿ UNIVERSITY OF CALGARY   (Canada)

^o SCARBOROUGH HOSPITAL   (Canada)

^p UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^q MCMASTER UNIVERSITY   (Canada)

^r QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

albuminuria kidney; Canadian Society of; chronic kidney; clinical practice guideline; disease (CKD) staging; disease progression; Estimated glomerular filtration; Global Outcomes (KDIGO); Kidney Disease: Improving; Nephrology (CSN); rate (eGFR)

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HUMAN ALBUMIN; METFORMIN;

ALBUMINURIA; ANEMIA; BLOOD PRESSURE; BODY SURFACE; CALIBRATION; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; HYPERURICEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; MEDICAL SOCIETY; METABOLIC BONE DISEASE; NEPHROLOGY; ORTHOSTATIC HYPOTENSION; PERIODIC MEDICAL EXAMINATION; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PREDICTION; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; REVIEW; SODIUM INTAKE; SODIUM RESTRICTION; TERMINAL CARE; CANADA; DISEASE MANAGEMENT; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; STANDARDS; TREATMENT OUTCOME;

CANADA; DISEASE MANAGEMENT; HUMANS; NEPHROLOGY; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84921556295     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.10.013     Document Type: Article

References (189)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 1 2013 1 150
2. R. Mustafa, A. Levin, and A. Akbari The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review Can J Kidney Health Dis 1 2014 5
3. GRADE working group. Grading the quality of evidence and the strength of recommendations. http://www.gradeworkinggroup.org/index.htm. Accessed February 4, 2014.
4. S.I. Hallan, K. Dahl, and C.M. Oien Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey BMJ 333 2006 1047
5. Chronic Kidney Disease Prognosis Consortium K. Matsushita, M. van der Velde, and B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
6. B.C. Astor, K. Matsushita, and R.T. Gansevoort Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts Kidney Int 79 2011 1331 1340
7. M. van der Velde, K. Matsushita, and J. Coresh Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 2011 1341 1352
8. A.H. Brantsma, S.J. Bakker, D. de Zeeuw, P.E. de Jong, and R.T. Gansevoort Prevend Study Group. Extended prognostic value of urinary albumin excretion for cardiovascular events J Am Soc Nephrol 19 2008 1785 1791
9. R.J. Glassock, M. El Nahas, and C.G. Winearls Chronic kidney disease in Taiwan [letter] Lancet 372 2008 1949 1950 author reply 1950-1941
10. B.R. Hemmelgarn, B.J. Manns, and A. Lloyd Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 2010 423 429
11. R.T. Gansevoort, K. Matsushita, and M. van der Velde Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 2011 93 104
12. P. Delanaye, and E. Cavalier Staging chronic kidney disease and estimating glomerular filtration rate: an opinion paper about the new international recommendations Clin Chem Lab Med 51 2013 1911 1917
13. L.A. Macdonald, D.L. Sackett, R.B. Haynes, and D.W. Taylor Labelling in hypertension: a review of the behavioural and psychological consequences J Chronic Dis 37 1984 933 942
14. M.E. Johnston, E.S. Gibson, and C.W. Terry Effects of labelling on income, work and social function among hypertensive employees J Chronic Dis 37 1984 417 423
15. A.J. Matas, and H.N. Ibrahim The unjustified classification of kidney donors as patients with CKD: critique and recommendations Clin J Am Soc Nephrol 8 2013 1406 1413
16. G.M. McMahon, and S.S. Waikar Biomarkers in nephrology: core curriculum 2013 Am J Kidney Dis 62 2013 165 178
17. L.A. Inker, C.H. Schmid, and H. Tighiouart Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 2012 20 29
18. 2-microglobulin, cystatin C, and creatinine in the US population Clin J Am Soc Nephrol 8 2013 584 592
19. M.G. Shlipak, K. Matsushita, and J. Arnlov Cystatin C versus creatinine in determining risk based on kidney function N Engl J Med 369 2013 932 943
20. C.Y. Hsu, and N. Bansal Measured GFR as "gold standard" - all that glitters is not gold? Clin J Am Soc Nephrol 6 2011 1813 1814
21. Y.K. Kagoma, M.A. Weir, and A.V. Iansavichus Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review Am J Kidney Dis 57 2011 592 601
22. A. Jain, and B.R. Hemmelgarn Impact of estimated glomerular filtration rate reporting on nephrology referrals: a review of the literature Curr Opin Nephrol Hypertens 20 2011 218 223
23. A.K. Jain, M.S. Cuerden, and I. McLeod Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD Kidney Int 81 2012 1248 1253
24. A. Farag, A.X. Garg, L. Li, and A.K. Jain Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis Am J Kidney Dis 63 2014 422 428
25. A. Akbari, J. Grimshaw, and D. Stacey Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration rate CMAJ 184 2012 E269 E276
26. D.M. Naimark, Z. Harel, R. Moineddin, and A. Bergman The impact of estimated glomerular filtration rate reporting on nephrology referral pattern, patient characteristics and outcome Nephron Clin Pract 121 2012 c10 c15
27. M.M. Sood, P. Komenda, C. Rigatto, B. Hiebert, and N. Tangri The association of eGFR reporting with the timing of dialysis initiation J Am Soc Nephrol 25 2014 2097 2104
28. C. Foote, P.A. Clayton, D.W. Johnson, M. Jardine, P. Snelling, and A. Cass Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Am J Kidney Dis 64 3 2014 359 366
29. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
30. P. Komenda, M. Beaulieu, D. Seccombe, and A. Levin Regional implementation of creatinine measurement standardization J Am Soc Nephrol 19 2008 164 169
31. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
32. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
33. L.A. Stevens, C.H. Schmid, and Y.L. Zhang Development and validation of GFR-estimating equations using diabetes, transplant and weight Nephrol Dial Transplant 25 2010 449 457
34. L.A. Stevens, C.H. Schmid, and T. Greene Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2 Am J Kidney Dis 56 2010 486 495
35. K. Matsushita, E. Selvin, L.D. Bash, B.C. Astor, and J. Coresh Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study Am J Kidney Dis 55 2010 648 659
36. L.A. Stevens, S. Li, and M. Kurella Tamura Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP) Am J Kidney Dis 57 suppl 2 2011 S9 S16
37. T. Shafi, K. Matsushita, and E. Selvin Comparing the association of GFR estimated by the CKD-EPI and MDRD Study equations and mortality: the Third National Health and Nutrition Examination Survey (NHANES III) BMC Nephrol 13 2012 42
38. K. Shaffi, K. Uhlig, and R.D. Perrone Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients Am J Kidney Dis 63 2014 1007 1018
39. M.P. McTaggart, C.P. Price, R.G. Pinnock, P.E. Stevens, R.G. Newall, and E.J. Lamb The diagnostic accuracy of a urine albumin-creatinine ratio point-of-care test for detection of albuminuria in primary care Am J Kidney Dis 60 2012 787 794
40. A. Duerksen, V. Dubey, and K. Iglar Annual adult health checkup: update on the Preventive Care Checklist Form((c)) Can Fam Physician 58 2012 43 47
41. R. John, M. Webb, A. Young, and P.E. Stevens Unreferred chronic kidney disease: a longitudinal study Am J Kidney Dis 43 2004 825 835
42. B.O. Eriksen, J. Tomtum, and O.C. Ingebretsen Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort Nephron Clin Pract 115 2010 c41 c50
43. G.D. James, J.E. Sealey, and M. Alderman A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences Am J Hypertens 1 1988 124 131
44. B.R. Hemmelgarn, J. Zhang, and B.J. Manns Progression of kidney dysfunction in the community-dwelling elderly Kidney Int 69 2006 2155 2161
45. J.T. Wright Jr., G. Bakris, and T. Greene Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431
46. S. Klahr, A.S. Levey, and G.J. Beck The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group N Engl J Med 330 1994 877 884
47. A.S. Levey, J.J. Gassman, P.M. Hall, and W.G. Walker Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group J Am Soc Nephrol 1 1991 1087 1094
48. A. Levin, O. Djurdjev, M. Beaulieu, and L. Er Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort Am J Kidney Dis 52 2008 661 671
49. T.C. Turin, J. Coresh, and M. Tonelli Short-term change in kidney function and risk of end-stage renal disease Nephrol Dial Transplant 27 2012 3835 3843
50. T.C. Turin, J. Coresh, and M. Tonelli One-year change in kidney function is associated with an increased mortality risk Am J Nephrol 36 2012 41 49
51. D.E. Rifkin, M.G. Shlipak, and R. Katz Rapid kidney function decline and mortality risk in older adults Arch Intern Med 168 2008 2212 2218
52. K. Matsushita, E. Selvin, L.D. Bash, N. Franceschini, B.C. Astor, and J. Coresh Change in estimated GFR associates with coronary heart disease and mortality J Am Soc Nephrol 20 2009 2617 2624
53. M.G. Shlipak, R. Katz, and B. Kestenbaum Rapid decline of kidney function increases cardiovascular risk in the elderly J Am Soc Nephrol 20 2009 2625 2630
54. Z. Al-Aly, A. Zeringue, and J. Fu Rate of kidney function decline associates with mortality J Am Soc Nephrol 21 2010 1961 1969
55. T.C. Turin, J. Coresh, and M. Tonelli Change in the estimated glomerular filtration rate over time and risk of all-cause mortality Kidney Int 83 2013 684 691
56. N. Tangri, G.D. Kitsios, and L.A. Inker Risk prediction models for patients with chronic kidney disease: a systematic review Ann Intern Med 158 2013 596 603
57. E.S. Johnson, M.L. Thorp, R.W. Platt, and D.H. Smith Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study Am J Kidney Dis 52 2008 653 660
58. N. Tangri, L.A. Stevens, and J. Griffith A predictive model for progression of chronic kidney disease to kidney failure JAMA 305 2011 1553 1559
59. N. Tangri, L.A. Stevens, and J. Griffith A predictive model for progression of chronic kidney disease to kidney failure JAMA 305 2011 1553 1559
60. M.J. Sarnak, T. Greene, and X. Wang The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study Ann Intern Med 142 2005 342 351
61. P. Ruggenenti, A. Perna, and G. Loriga Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial Lancet 365 2005 939 946
62. L.J. Appel, J.T. Wright Jr., and T. Greene Intensive blood-pressure control in hypertensive chronic kidney disease N Engl J Med 363 2010 918 929
63. A. Upadhyay, A. Earley, S.M. Haynes, and K. Uhlig Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier Ann Intern Med 154 2011 541 548
64. J. Lv, P. Ehteshami, and M.J. Sarnak Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis CMAJ 185 2013 949 957
65. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
66. Accord Study Group W.C. Cushman, G.W. Evans, and R.P. Byington Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
67. K. McBrien, D.M. Rabi, and N. Campbell Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis Arch Intern Med 172 2012 1296 1303
68. M. Ruzicka, R.R. Quinn, and P. McFarlane Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD Am J Kidney Dis 63 2014 869 887
69. ONTARGET Investigators S. Yusuf, K.K. Teo, and J. Pogue Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559
70. J.F. Mann, R.E. Schmieder, and M. McQueen Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET Study): a multicentre, randomised, double-blind, controlled trial Lancet 372 2008 547 553
71. L.F. Fried, N. Emanuele, and J.H. Zhang Combined angiotensin inhibition for the treatment of diabetic nephropathy N Engl J Med 369 2013 1892 1903
72. Escape Trial Group E. Wuhl, A. Trivelli, and S. Picca Strict blood-pressure control and progression of renal failure in children N Engl J Med 361 2009 1639 1650
73. M. James, J. Bouchard, and J. Ho Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury Am J Kidney Dis 61 2013 673 685
74. L. Robertson, N. Waugh, and A. Robertson Protein restriction for diabetic renal disease Cochrane Database Syst Rev 4 2007 CD002181
75. D. Fouque, and M. Laville Low protein diets for chronic kidney disease in non diabetic adults Cochrane Database Syst Rev 3 2009 CD001892
76. W.E. Mitch Dietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency J Am Soc Nephrol 2 1991 823 831
77. J.D. Kopple, A.S. Levey, and T. Greene Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study Kidney Int 52 1997 778 791
78. M. Aparicio, P. Chauveau, V. De Precigout, J.L. Bouchet, C. Lasseur, and C. Combe Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet J Am Soc Nephrol 11 2000 708 716
79. J. Bernhard, B. Beaufrere, M. Laville, and D. Fouque Adaptive response to a low-protein diet in predialysis chronic renal failure patients J Am Soc Nephrol 12 2001 1249 1254
80. V. Menon, J.D. Kopple, and X. Wang Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study Am J Kidney Dis 53 2009 208 217
81. C.G. Rabbat Review: a low-protein diet delays end-stage renal disease or death in stage 3 to 5 chronic kidney disease ACP J Club 145 2006 64
82. L.L. Woods Mechanisms of renal hemodynamic regulation in response to protein feeding Kidney Int 44 1993 659 675
83. A.J. King, and A.S. Levey Dietary protein and renal function J Am Soc Nephrol 3 1993 1723 1737
84. H.J. Bilo, G.H. Schaap, E. Blaak, R.O. Gans, P.L. Oe, and A.J. Donker Effects of chronic and acute protein administration on renal function in patients with chronic renal insufficiency Nephron 53 1989 181 187
85. K.R. Tuttle, M.E. Puhlman, S.K. Cooney, and R.A. Short Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes Am J Physiol Renal Physiol 282 2002 F103 F112
86. E.L. Knight, M.J. Stampfer, S.E. Hankinson, D. Spiegelman, and G.C. Curhan The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency Ann Intern Med 138 2003 460 467
87. A. Parikh, S.R. Lipsitz, and S. Natarajan Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study Am J Hypertens 22 2009 409 416
88. F. Sofi, R. Abbate, G.F. Gensini, and A. Casini Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis Am J Clin Nutr 92 2010 1189 1196
89. D. Dunkler, M. Dehghan, and K.K. Teo Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus JAMA Intern Med 173 18 2013 1682 1692
90. S. Chaturvedi, and C. Jones Protein restriction for children with chronic kidney disease Cochrane Database Syst Rev 4 2007 CD006863
91. F. Ismail-Beigi, T. Craven, and M.A. Banerji Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 2010 419 430
92. Y. Ohkubo, H. Kishikawa, and E. Araki Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res Clin Pract 28 1995 103 117
93. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
94. Advance Collaborative Group A. Patel, S. MacMahon, and J. Chalmers Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
95. S.R. Levin, J.W. Coburn, and C. Abraira Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators Diabetes Care 23 2000 1478 1485
96. E.S. Huang, Q. Zhang, N. Gandra, M.H. Chin, and D.O. Meltzer The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis Ann Intern Med 149 2008 11 19
97. D.E. Bonds, M.E. Miller, and R.M. Bergenstal The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD Study BMJ 340 2010 b4909
98. H.J. Lambers Heerspink, F.A. Holtkamp, and H.H. Parving Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers Kidney Int 82 2012 330 337
99. S. Vegter, A. Perna, M.J. Postma, G. Navis, G. Remuzzi, and P. Ruggenenti Sodium intake, ACE inhibition, and progression to ESRD J Am Soc Nephrol 23 2012 165 173
100. A. Smyth, M.J. O'Donnell, and S. Yusuf Sodium intake and renal outcomes: a systematic review Am J Hypertens 27 2014 1277 1284
101. A. Smyth, D. Dunkler, and P. Gao The relationship between estimated sodium and potassium excretion and subsequent renal outcomes [published online ahead of print June 11, 2014] Kidney Int 2014 10.1038/ki.2014.214
102. N.J. Aburto, A. Ziolkovska, L. Hooper, P. Elliott, F.P. Cappuccio, and J.J. Meerpohl Effect of lower sodium intake on health: systematic review and meta-analyses BMJ 346 2013 f1326
103. M.J. O'Donnell, S. Yusuf, and A. Mente Urinary sodium and potassium excretion and risk of cardiovascular events JAMA 306 2011 2229 2238
104. M.C. Thomas, J. Moran, and C. Forsblom The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes Diabetes Care 34 2011 861 866
105. H.W. Cohen, S.M. Hailpern, J. Fang, and M.H. Alderman Sodium intake and mortality in the NHANES II follow-up study Am J Med 119 2006 275. e277-e214
106. E.I. Ekinci, S. Clarke, and M.C. Thomas Dietary salt intake and mortality in patients with type 2 diabetes Diabetes Care 34 2011 703 709
107. K. Stolarz-Skrzypek, T. Kuznetsova, and L. Thijs Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion JAMA 305 2011 1777 1785
108. Health Canada. Sodium in Canada. http://www.hc-sc.gc.ca/fn-an/nutrition/sodium/index-eng.php#a2 Accessed February 8, 2014.
109. K.L. Campbell, D.W. Johnson, and J.D. Bauer A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients BMC Nephrol 15 2014 57
110. Centers for Disease Control and Prevention Vital signs: food categories contributing the most to sodium consumption - United States, 2007-2008 MMWR Morbid Mortal Wkly Rep 61 2012 92 98
111. N. Karanja, K.J. Lancaster, and W.M. Vollmer Acceptability of sodium-reduced research diets, including the Dietary Approaches to Stop Hypertension diet, among adults with prehypertension and stage 1 hypertension J Am Diet Assoc 107 2007 1530 1538
112. C.M. Clase, B.A. Kiberd, and A.X. Garg Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III) Nephron Clin Pract 105 2007 c178 c184
113. O. Moranne, M. Froissart, and J. Rossert Timing of onset of CKD-related metabolic complications J Am Soc Nephrol 20 2009 164 171
114. I. de Brito-Ashurst, L. Perry, and T.A. Sanders The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial Heart 99 2013 1256 1260
115. L.M. Moist, S. Troyanov, and C.T. White Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD Am J Kidney Dis 62 2013 860 873
116. J.A. Vassalotti, J. Uribarri, and S.C. Chen Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004 Am J Kidney Dis 51 suppl 2 2008 S56 S68
117. N. Tangri, M. Wagner, and J.L. Griffith Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry Am J Kidney Dis 57 2011 415 421
118. S.A. Jamal, B. Vandermeer, and P. Raggi Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis Lancet 382 2013 1268 1277
119. S. Hiremath, and A. Akbari Calcium-based phosphate binders and chronic kidney disease Lancet 383 2014 216
120. R. Vieth Why "vitamin D" is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoids J Steroid Biochem Mol Biol 89-90 2004 571 573
121. T. Janz, and C. Pearson Vitamin D Blood Levels of Canadians 2013 Statistics Canada Ottawa, Canada
122. R. Mehrotra, D. Kermah, and M. Budoff Hypovitaminosis D in chronic kidney disease Clin J Am Soc Nephrol 3 2008 1144 1151
123. S.D. Navaneethan, J.D. Schold, and S. Arrigain Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD Am J Kidney Dis 58 2011 536 543
124. S. Williams, K. Malatesta, and K. Norris Vitamin D and chronic kidney disease Ethn Dis 19 suppl 5 2009 S5 8-11
125. P. Kandula, M. Dobre, J.D. Schold, M.J. Schreiber Jr., R. Mehrotra, and S.D. Navaneethan Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials Clin J Am Soc Nephrol 6 2011 50 62
126. M.F. Holick Vitamin D: extraskeletal health Rheum Dis Clin North Am 38 2012 141 160
127. A. Levin, G.L. Bakris, and M. Molitch Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 2007 31 38
128. Health Canada. Vitamin D and calcium: updated dietary reference intakes. http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php#a4. Accessed February 8, 2014.
129. D.A. Hanley, A. Cranney, and G. Jones Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada CMAJ 182 2010 E610 E618
130. J.L. Gorriz, P. Molina, and J. Bover Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE Study Nefrologia 33 2013 46 60
131. T.H. Driver, M.G. Shlipak, and R. Katz Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) Am J Kidney Dis 64 4 2014 534 541
132. I. de Brito-Ashurst, M. Varagunam, M.J. Raftery, and M.M. Yaqoob Bicarbonate supplementation slows progression of CKD and improves nutritional status J Am Soc Nephrol 20 2009 2075 2084
133. C. Baigent, M.J. Landray, and C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192
134. M.L. Boyce, R.A. Robergs, and P.S. Avasthi Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension, and renal function Am J Kidney Dis 30 1997 180 192
135. J.M. Halimi, B. Giraudeau, and S. Vol Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population Kidney Int 58 2000 1285 1292
136. J.B. Olesen, G.Y. Lip, and A.L. Kamper Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
137. S.C. Palmer, L. Di Micco, and M. Razavian Antiplatelet agents for chronic kidney disease Cochrane Database Syst Rev 2 2013 CD008834
138. S.C. Palmer, L. Di Micco, and M. Razavian Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis Ann Intern Med 156 2012 445 459
139. R.J. Aviles, A.T. Askari, and B. Lindahl Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction N Engl J Med 346 2002 2047 2052
140. J.H. Ix, R. Katz, and I.H. De Boer Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study) J Am Coll Cardiol 54 2009 1176 1184
141. K.A. Wargo, and T.M. English Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for dosing antimicrobials Ann Pharmacother 44 2010 439 446
142. K.A. Wargo, E.H. Eiland III, W. Hamm, T.M. English, and H.M. Phillippe Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for antimicrobial dosage adjustments Ann Pharmacother 40 2006 1248 1253
143. L.A. Stevens, T.D. Nolin, and M.M. Richardson Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations Am J Kidney Dis 54 2009 33 42
144. M.C. Laliberte, M. Normandeau, and A. Lord Use of over-The-counter medications and natural products in patients with moderate and severe chronic renal insufficiency Am J Kidney Dis 49 2007 245 256
145. A. Frid, G.N. Sterner, and M. Londahl Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations Diabetes Care 33 2010 1291 1293
146. J.D. Lalau, A. Vermersch, L. Hary, M. Andrejak, F. Isnard, and J. Quichaud Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly) Int J Clin Pharmacol Ther Toxicol 28 1990 329 332
147. N.C. Sambol, J. Chiang, and E.T. Lin Kidney function and age are both predictors of pharmacokinetics of metformin J Clin Pharmacol 35 1995 1094 1102
148. G.T. Tucker, C. Casey, P.J. Phillips, H. Connor, J.D. Ward, and H.F. Woods Metformin kinetics in healthy subjects and in patients with diabetes mellitus Br J Clin Pharmacol 12 1981 235 246
149. S.R. Salpeter, E. Greyber, G.A. Pasternak, and E.E. Salpeter Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus Cochrane Database Syst Rev 4 2010 CD002967
150. J.D. Lalau, and J.M. Race Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations Drug Saf 20 1999 377 384
151. R. Roussel, F. Travert, and B. Pasquet Metformin use and mortality among patients with diabetes and atherothrombosis Arch Intern Med 170 2010 1892 1899
152. N. Ekstrom, L. Schioler, and A.M. Svensson Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register BMJ Open 2 2012 e001076
153. R. Rachmani, I. Slavachevsky, Z. Levi, B.-S. Zadok, Y. Kedar, and M. Ravid Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications Eur J Int Med 13 2002 428 433
154. A. Saenz, I. Fernandez-Esteban, A. Mataix, M. Ausejo, M. Roque, and D. Moher Metformin monotherapy for type 2 diabetes mellitus Cochrane Database Syst Rev 3 2005 CD002966
155. P. Aschner, M.S. Kipnes, and J.K. Lunceford Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes Diabetes Care 29 2006 2632 2637
156. M.A. Nauck, G. Meininger, D. Sheng, L. Terranella, P.P. Stein Sitagliptin Study Group Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial Diabetes Obes Metab 9 2007 194 205
157. J.C. Chan, R. Scott, and J.C. Arjona Ferreira Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency Diabetes Obes Metab 10 2008 545 555
158. J.C. Arjona Ferreira, M. Marre, and N. Barzilai Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency Diabetes Care 36 2013 1067 1073
159. V.S. Eligar, and S.C. Bain A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment Drug Design Dev Ther 7 2013 893 903
160. Public Health Agency of Canada. Publicly-funded immunization programs in the provinces and territories of Canada. Definitions of high risk for respiratory diseases (as of September 2014). http://www.phac-aspc.gc.ca/im/ptimprog-progimpt/table-7-eng.php. Accessed November 24, 2014.
161. M. Dinits-Pensy, G.N. Forrest, A.S. Cross, and M.K. Hise The use of vaccines in adult patients with renal disease Am J Kidney Dis 46 2005 997 1011
162. B.R. Hemmelgarn, B.J. Manns, and J. Zhang Association between multidisciplinary care and survival for elderly patients with chronic kidney disease J Am Soc Nephrol 18 2007 993 999
163. A.H. Zhang, P. Tam, and D. LeBlanc Natural history of CKD stage 4 and 5 patients following referral to renal management clinic Int Urol Nephrol 41 2009 977 982
164. P.E. Ronksley, and B.R. Hemmelgarn Optimizing care for patients with CKD Am J Kidney Dis 60 2012 133 138
165. R.B. Hopkins, A.X. Garg, and A. Levin Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease Clin J Am Soc Nephrol 6 2011 1248 1257
166. C. De Coster, K. McLaughlin, and T.W. Noseworthy Criteria for referring patients with renal disease for nephrology consultation: a review of the literature J Nephrol 23 2010 399 407
167. S.I. Hallan, E. Ritz, S. Lydersen, S. Romundstad, K. Kvenild, and S.R. Orth Combining GFR and albuminuria to classify CKD improves prediction of ESRD J Am Soc Nephrol 20 2009 1069 1077
168. A.P. Amin, A.T. Whaley-Connell, and S. Li The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP) Am J Kidney Dis 61 suppl 2 2013 S12 23
169. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease Kidney Int Suppl 2 2012 337 414
170. C.L. Hall, R. Bradley, A. Kerr, R. Attoti, and D. Peat Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria Clin Nephrol 62 2004 267 272
171. G.E. Nesrallah, R.A. Mustafa, and W.F. Clark Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis CMAJ 186 2014 112 117
172. S.V. Jassal, E.E. Kelman, and D. Watson Non-dialysis care: an important component of care for elderly individuals with advanced stages of chronic kidney disease Nephron Clin Pract 119 suppl 1 2011 c5 c9
173. D.C. Brennan, G. Vedala, and S.B. Miller Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates Transplant Proc 29 1997 233 234
174. J.J. De Lima, E. Sabbaga, and M.L. Vieira Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing Hypertension 42 2003 263 268
175. P.A. Ferreira, V.C. de Lima, and O. Campos Filho Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates Arq Bras Cardiol 88 2007 45 51
176. S. Gang, M. Dabhi, and M.M. Rajapurkar Ischaemia imaging in type 2 diabetic kidney transplant candidates - is coronary angiography essential? Nephrol Dial Transplant 22 2007 2334 2338
177. C. Garcia-Canton, C. Culebras, and M. Hernandez-Briz Dobutamine stress echocardiography and stress 99m-technetium methoxyisobutylisonitrile SPECT in the assessment of coronary artery disease in kidney transplant candidates [ASN abstract A3603] J Am Soc Nephrol 9 1998 815
178. C.A. Herzog, T.H. Marwick, A.M. Pheley, C.W. White, V.K. Rao, and C.D. Dick Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates Am J Kidney Dis 33 1999 1080 1090
179. D.S. Jassal, T.G. Neilan, M.H. Picard, and M.J. Wood Stress echocardiography: abnormal response of tissue Doppler-derived indices to dobutamine in the absence of obstructive coronary artery disease in patients with chronic renal failure Echocardiography 24 2007 580 586
180. G. Reis, P.A. Marcovitz, and A.B. Leichtman Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease Am J Cardiol 75 1995 707 710
181. R. Sharma, R.L. Mehta, and S.J. Brecker The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease Coron Artery Dis 20 2009 230 237
182. R. Sharma, D. Pellerin, and D.C. Gaze Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates Nephrol Dial Transplant 20 2005 2207 2214
183. J.C. West, D.A. Napoliello, and J.M. Costello Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation Transpl Int 13 suppl 1 2000 S27 S30
184. R.J. Boudreau, J.T. Strony, and R.P. duCret Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration Radiology 175 1990 103 105
185. N. Garg, A. Kapoor, C.V. Umesan, R.K. Sharma, and N. Sinha Role of pretransplant arteriography in diabetic end-stage renal disease Asian Cardiovasc Thorac Ann 8 2000 150 154
186. T.H. Marwick, D.R. Steinmuller, and D.A. Underwood Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure Transplantation 49 1990 100 103
187. B.F. Vandenberg, J.D. Rossen, M. Grover-McKay, N.W. Shammas, T.L. Burns, and K. Rezai Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods Transplantation 62 1996 1230 1235
188. M.I. Worthley, S.A. Unger, T.H. Mathew, G.R. Russ, and J.D. Horowitz Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure Am J Cardiol 92 2003 1318 1320
189. W.M. Bennett, F. Kloster, J. Rosch, J. Barry, and G.A. Porter Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease Am J Med 65 1978 779 784